Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.810
-0.060 (-2.09%)
At close: Mar 20, 2026, 4:00 PM EDT
2.760
-0.050 (-1.78%)
After-hours: Mar 20, 2026, 4:10 PM EDT
CNTB Revenue
Connect Biopharma Holdings had revenue of $16.00K in the quarter ending September 30, 2025, a decrease of -98.69%. This brings the company's revenue in the last twelve months to $762.00K, down -96.99% year-over-year. In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M.
Revenue (ttm)
$762.00K
Revenue Growth
-96.99%
P/S Ratio
202.49
Revenue / Employee
$12,290
Employees
62
Market Cap
154.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.03M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Jan 1, 2022 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 154.90M |
| Precision BioSciences | 34.26M |
| NovaBay Pharmaceuticals | 10.30M |
| Evaxion | 7.53M |
| Korro Bio | 6.39M |
| Humacyte | 1.57M |
CNTB News
- 11 days ago - Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - GlobeNewsWire
- 18 days ago - Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 2 months ago - Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026 - GlobeNewsWire
- 4 months ago - Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript - Seeking Alpha
- 6 months ago - Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025 - GlobeNewsWire